The Healthcare Technology Report’s Awardees Represent the “Absolute Best” in the Healthcare Technology Space
Horsham, Pa.; August 4, 2022 — Clinical ink, a global life science technology company, has been named a Top 100 Healthcare Technology Company of 2022 by The Healthcare Technology Report. From large pharmaceutical sponsors and genomics start-ups to innovative clinical data companies like Clinical ink, this year’s awardees are changing the face of the healthcare industry—leveraging considerable talent to find innovative solutions for healthcare’s most pressing issues.
“We are honored to be named on this year’s Top 100 Healthcare Technology Company list,” said Clinical ink Chief Executive Officer Ed Seguine. “At Clinical ink, we are constantly working to power patient outcomes by converging data, technology, and patient science. This honor demonstrates the impact we’ve made in areas as diverse as Alzheimers, Parkinsons, Neuroscience, Immunology, and other complex conditions. Our latest innovations in digital sensors, voice, and decentralized trial functionality will continue to drive advancements in clinical discovery.”
The top 100 companies of 2022 represent a range of specialties, but the common thread is the impact they are having on patient lives, whether through direct treatment or by providing advanced, game-changing products and services. Among the key criteria considered were product or service quality, customer adoption, management team caliber, organizational effectiveness, and company growth—among other factors.
Along with this award, in the past year, Clinical ink was listed on 2021’s Deloitte Technology Fast 500 and nominated as Technology Company of the Year by the Philadelphia Alliance for Capital and Technologies (PACT), which celebrates the achievement and innovation of life sciences leaders.
About Clinical ink Clinical ink is the global life science company that brings data, technology, and patient science together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials. By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.
About The Healthcare Technology Report The Healthcare Technology Report is your comprehensive source for business news, investment activity and corporate actions related to healthcare technology. We provide industry executives, professionals, and investors important news and information on the healthcare technology industry.